Development of new therapies, including regeneration of the kidney, for chronic kidney diseases

Matsuhiko Hayashi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The increasing number of patients on chronic hemodialysis is a great problem in the field of nephrology in Japan and Western countries. Current therapies for chronic kidney diseases (CKDs) can retard the progression of renal failure, but cannot completely stop their progression to endstage renal failure (ESRD). Many researchers are now studying new therapeutic targets for CKDs, by various methods. Furthermore, because organ donation for kidney transplantation is very limited in Japan, research on kidney regeneration is an important issue for the therapy of ESRD. To regenerate the kidney, stem cells and growth factors for the kidney are being extensively studied, although the clinical application of the results of these studies has not yet taken place.

Original languageEnglish
Pages (from-to)99-101
Number of pages3
JournalClinical and Experimental Nephrology
Volume10
Issue number2
DOIs
Publication statusPublished - 2006 Jun

Fingerprint

Chronic Renal Insufficiency
Regeneration
Kidney
Chronic Kidney Failure
Renal Insufficiency
Japan
Stem Cell Factor
Tissue and Organ Procurement
Nephrology
Kidney Transplantation
Renal Dialysis
Intercellular Signaling Peptides and Proteins
Therapeutics
Research Personnel
Research

Keywords

  • Kidney
  • Microarray
  • Prorenin
  • Regeneration
  • Stem cell

ASJC Scopus subject areas

  • Nephrology

Cite this

Development of new therapies, including regeneration of the kidney, for chronic kidney diseases. / Hayashi, Matsuhiko.

In: Clinical and Experimental Nephrology, Vol. 10, No. 2, 06.2006, p. 99-101.

Research output: Contribution to journalArticle

@article{7e75f4896e074a33835860c87490f8c4,
title = "Development of new therapies, including regeneration of the kidney, for chronic kidney diseases",
abstract = "The increasing number of patients on chronic hemodialysis is a great problem in the field of nephrology in Japan and Western countries. Current therapies for chronic kidney diseases (CKDs) can retard the progression of renal failure, but cannot completely stop their progression to endstage renal failure (ESRD). Many researchers are now studying new therapeutic targets for CKDs, by various methods. Furthermore, because organ donation for kidney transplantation is very limited in Japan, research on kidney regeneration is an important issue for the therapy of ESRD. To regenerate the kidney, stem cells and growth factors for the kidney are being extensively studied, although the clinical application of the results of these studies has not yet taken place.",
keywords = "Kidney, Microarray, Prorenin, Regeneration, Stem cell",
author = "Matsuhiko Hayashi",
year = "2006",
month = "6",
doi = "10.1007/s10157-006-0418-7",
language = "English",
volume = "10",
pages = "99--101",
journal = "Clinical and Experimental Nephrology",
issn = "1342-1751",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Development of new therapies, including regeneration of the kidney, for chronic kidney diseases

AU - Hayashi, Matsuhiko

PY - 2006/6

Y1 - 2006/6

N2 - The increasing number of patients on chronic hemodialysis is a great problem in the field of nephrology in Japan and Western countries. Current therapies for chronic kidney diseases (CKDs) can retard the progression of renal failure, but cannot completely stop their progression to endstage renal failure (ESRD). Many researchers are now studying new therapeutic targets for CKDs, by various methods. Furthermore, because organ donation for kidney transplantation is very limited in Japan, research on kidney regeneration is an important issue for the therapy of ESRD. To regenerate the kidney, stem cells and growth factors for the kidney are being extensively studied, although the clinical application of the results of these studies has not yet taken place.

AB - The increasing number of patients on chronic hemodialysis is a great problem in the field of nephrology in Japan and Western countries. Current therapies for chronic kidney diseases (CKDs) can retard the progression of renal failure, but cannot completely stop their progression to endstage renal failure (ESRD). Many researchers are now studying new therapeutic targets for CKDs, by various methods. Furthermore, because organ donation for kidney transplantation is very limited in Japan, research on kidney regeneration is an important issue for the therapy of ESRD. To regenerate the kidney, stem cells and growth factors for the kidney are being extensively studied, although the clinical application of the results of these studies has not yet taken place.

KW - Kidney

KW - Microarray

KW - Prorenin

KW - Regeneration

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=33745490054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745490054&partnerID=8YFLogxK

U2 - 10.1007/s10157-006-0418-7

DO - 10.1007/s10157-006-0418-7

M3 - Article

C2 - 16791394

AN - SCOPUS:33745490054

VL - 10

SP - 99

EP - 101

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 2

ER -